Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
Buy
75
LFVN Quote, Financials, Valuation and Earnings
Last price:
$16.48
Seasonality move
:
31.99%
Day range:
$16.62 - $17.97
52-week range:
$5.22 - $19.06
Dividend yield:
0.93%
P/E ratio:
52.31x
P/S ratio:
1.10x
P/B ratio:
7.57x
Volume:
98.5K
Avg. volume:
89.2K
1-year change:
196.28%
Market cap:
$209.7M
Revenue:
$200.2M
EPS (TTM):
$0.32
Analysts' Opinion
-
Consensus RatingLifevantage has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Lifevantage has an estimated upside of 55.32% from its current price of $16.74.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $16.74.
Fair Value
-
According to the consensus of 0 analysts, Lifevantage has 55.32% upside to fair value with a price target of -- per share.
LFVN vs. S&P 500
-
Over the past 5 trading days, Lifevantage has underperformed the S&P 500 by -7.69% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Lifevantage does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lifevantage revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Lifevantage reported revenues of $47.2M.
Earnings Growth
-
Lifevantage has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Lifevantage reported earnings per share of $0.14.
Enterprise value:
195.1M
EV / Invested capital:
--
Price / LTM sales:
1.10x
EV / EBIT:
31.70x
EV / Revenue:
1.00x
PEG ratio (5yr expected):
0.87x
EV / Free cash flow:
36.21x
Price / Operating cash flow:
39.87x
Enterprise value / EBITDA:
20.29x
Gross Profit (TTM):
$155.3M
Return On Assets:
6.62%
Net Income Margin (TTM):
2.11%
Return On Equity:
15.08%
Return On Invested Capital:
15.08%
Operating Margin:
5.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $204.9M | $213M | $196M | $51.4M | $47.2M | |
| Gross Profit | $166.3M | $169.4M | $155.3M | $41.2M | $37.7M | |
| Operating Income | $4.3M | $3.7M | $6.2M | $749K | $2.6M | |
| EBITDA | $4.5M | $7.4M | $9.6M | $1.7M | $3.4M | |
| Diluted EPS | $0.04 | $0.20 | $0.32 | $0.05 | $0.14 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $41M | $44.9M | $42.9M | $41.9M | $38.8M | |
| Total Assets | $70.2M | $75.6M | $67.6M | $66.6M | $61.5M | |
| Current Liabilities | $22M | $22.3M | $22.8M | $24.7M | $22.1M | |
| Total Liabilities | $36.1M | $38.3M | $35.7M | $37.3M | $33.8M | |
| Total Equity | $34.1M | $37.3M | $31.9M | $29.3M | $27.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $6.1M | $12.9M | $6.8M | $4.8M | -$583K | |
| Cash From Investing | -$1.9M | -$3.5M | -$1.5M | -$1.1M | -$345K | |
| Cash From Financing | -$6M | -$8.7M | -$9.6M | -$6.7M | -$1.8M | |
| Free Cash Flow | $4.3M | $9.5M | $5.4M | $3.6M | -$932K | |
LFVN
Sector
Market Cap
$209.7M
$327.2M
Price % of 52-Week High
87.83%
72.58%
Dividend Yield
0.93%
0%
Shareholder Yield
6.45%
2.68%
1-Year Price Total Return
196.28%
-13.49%
Beta (5-Year)
0.821
0.503
Dividend yield:
0.93%
Annualized payout:
$0.55
Payout ratio:
46.11%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$17.70
200-day SMA
Buy
Level
$9.73
Bollinger Bands (100)
Buy
Level
9.82 - 15.46
Chaikin Money Flow
Buy
Level
25.9M
20-day SMA
Buy
Level
$16.57
Relative Strength Index (RSI14)
Buy
Level
53.29
ADX Line
Buy
Level
26.6
Williams %R
Neutral
Level
-62.5337
50-day SMA
Buy
Level
$14.91
MACD (12, 26)
Buy
Level
0.85
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Neutral
Level
23.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7418)
Buy
CA Score
(Annual)
Level (0.996)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (1.304)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Stock Forecast FAQ
In the current month, LFVN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LFVN average analyst price target in the past 3 months is --.
-
Where Will Lifevantage Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lifevantage share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Lifevantage?
Analysts are divided on their view about Lifevantage share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lifevantage is a Sell and believe this share price will drop from its current level to --.
-
What Is Lifevantage's Price Target?
The price target for Lifevantage over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LFVN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lifevantage is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of LFVN?
You can purchase shares of Lifevantage via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lifevantage shares.
-
What Is The Lifevantage Share Price Today?
Lifevantage was last trading at $16.48 per share. This represents the most recent stock quote for Lifevantage. Yesterday, Lifevantage closed at $16.74 per share.
-
How To Buy Lifevantage Stock Online?
In order to purchase Lifevantage stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
